Circulating Tissue Polypeptide-Specific Antigen in Pre-Diagnostic Pancreatic Cancer Samples
Early detection of pancreatic ductal adenocarcinoma (PDAC) is challenging, and late diagnosis partly explains the low 5-year survival. Novel and sensitive biomarkers are needed to enable early PDAC detection and improve patient outcomes. Tissue polypeptide specific antigen (TPS) has been studied as...
Guardado en:
Autores principales: | Emmy Borgmästars, Erik Lundberg, Daniel Öhlund, Hanna Nyström, Oskar Franklin, Christina Lundin, Pär Jonsson, Malin Sund |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e121675efd024bdaa6885df50ba5efb1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Protective or Risk Factors for Postoperative Pancreatic Fistulas in Malignant Pathology
por: Alin Mihai Vasilescu, et al.
Publicado: (2021) -
Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits
por: Parniyan Maneshi, et al.
Publicado: (2021) -
Genomic Instability of Circulating Tumor DNA as a Prognostic Marker for Pancreatic Cancer Survival: A Prospective Cohort Study
por: Sang Myung Woo, et al.
Publicado: (2021) -
Activation of a Ductal-to-Endocrine Transdifferentiation Transcriptional Program in the Pancreatic Cancer Cell Line PANC-1 Is Controlled by RAC1 and RAC1b through Antagonistic Regulation of Stemness Factors
por: Paula Marie Schmidtlein, et al.
Publicado: (2021) -
Neoplasia mucinosa intraductal del páncreas
por: Butte,Jean M, et al.
Publicado: (2008)